Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine Injection for Pain Relief in Male Rigid Cystoscopy
NCT06301308Phase 3Withdrawn
- Sponsor
- The Second Xiangya Hospital
- Start
- Oct 2023
- Primary completion
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of lidocaine 10% oropharyngeal spray in bladder cancer, sponsored by The Second Xiangya Hospital. Planned start Oct 2023; status: withdrawn.
02
Drugs
lidocaine 10% oropharyngeal spray
03
Conditions
bladder cancer
Beyond the preview
Go deeper on NCT06301308.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06301308.